rs15561

This is a 3 prime utr variant variant in the NAT1 gene.

Research that mentions this SNP (4)

The role of ABCB1 polymorphism as a prognostic marker for primary central nervous system lymphoma
AssociationN=91Ting Wu et al.(2019)· Annals of Hematology

A prospective study of 91 primary central nervous system lymphoma (PCNSL) patients examined genetic polymorphisms in DNA repair, one-carbon metabolism, and metabolism genes as prognostic markers. ABCB1 rs1045642 was identified as an independent prognostic factor, with the CC genotype significantly associated with shorter progression-free survival (PFS: 16 months CC vs. 27 months TT/CT, HR=1.9, P=0.036) and higher risk of disease progression compared to T allele carriers.

Traits studied:Overall survivalPrimary central nervous system lymphoma (PCNSL)Progression-free survival
Impact of interactions of cigarette smoking with NAT2 polymorphisms on rheumatoid arthritis risk in African Americans
AssociationN=995Mikuls TR et al.(2012)· Arthritis & Rheumatism

This case-control study examined gene-environment interactions between smoking and drug-metabolizing enzyme (DME) polymorphisms in rheumatoid arthritis (RA) risk among 727 African American RA cases and 268 controls. While no individual DME genotypes were significantly associated with RA, significant additive interactions were found between heavy smoking (≥10 pack-years) and NAT2 SNPs rs9987109 (P_add=0.000003) and rs1208 (P_add=0.00001), with attributable proportions ranging from 0.61-0.67. The NAT2 rs1208 haplotype was associated with a 4.15-fold increased RA risk in heavy smokers (p=0.005).

Traits studied:RA (anti-citrullinated protein antibody positive)Rheumatoid Arthritis
Differential haplotype amplification leads to misgenotyping of heterozygote as homozygote when using single nucleotide mismatch primer
MethodsNavonil De Sarkar et al.(2012)· ELECTROPHORESIS

This methods paper demonstrates that single-nucleotide mismatches in primers located close to target SNPs cause preferential amplification of one haplotype strand, leading to misgenotyping of heterozygotes as homozygotes in PCR and sequencing-based genotyping. The study examined NAT1 (rs1057126, rs15561) and TP53 (rs12947788, rs12951053) loci, showing misgenotyping reaches 100% when mismatches are at the 3rd nucleotide position from the 3' primer end, but decreases significantly as mismatch position shifts toward the 5' end.

Functional effects of genetic polymorphisms in the N-acetyltransferase 1 coding and 3′ untranslated regions
FunctionalZhu Y. et al.(2011)· Birth Defects Research Part A: Clinical and Molecular Teratology

This functional study investigated the effects of NAT1 (N-acetyltransferase 1) genetic polymorphisms in the coding region and 3'-UTR on enzyme activity, mRNA, and protein levels using recombinant expression in COS-1 cells. The 1088T>A (rs1057126) and 1095C>A (rs15561) variants slightly reduced NAT1 catalytic activity and expression levels. A 9-base pair deletion in the 3'-UTR reduced activity, while the 445G>A (rs4987076), 459G>A (rs4986990), and 640T>G (rs4986783) coding region haplotype increased activity. These findings provide biological support for previously reported associations of 1088T>A and 1095C>A polymorphisms with birth defects including oral clefts and limb deficiency.

Traits studied:Acetylation phenotypeBirth defectsLimb deficiencyOral cleftsSpina bifida

About NAT1

This gene is one of two arylamine N-acetyltransferase (NAT) genes in the human genome, and is orthologous to the mouse and rat Nat2 genes. The enzyme encoded by this gene catalyzes the transfer of an acetyl group from acetyl-CoA to various arylamine and hydrazine substrates. This enzyme helps metabolize drugs and other xenobiotics, and functions in folate catabolism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]

View all NAT1 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…